K. Balogh

发表

Mucosally delivered peptides prime strong immunity in HLA-A2.1 transgenic rabbits.

N. Christensen, N. Cladel, Jiafen Hu, 2010, Vaccine.

DNA Vaccines Delivered By Microneedle and Tattoo Gun Induce Protective Immune Responses to Hla-A2.1 Restricted CRPV E1 and HPV16e7 Epitopes in HLA-A2.1 Transgenic Rabbits

N. Christensen, N. Cladel, L. Budgeon, 2016 .

Mouse papillomavirus MmuPV1 infects oral mucosa and preferentially targets the base of the tongue.

N. Christensen, N. Cladel, T. Cooper, 2016, Virology.

A Novel Pre-Clinical Murine Model to Study the Life Cycle and Progression of Cervical and Anal Papillomavirus Infections

N. Christensen, N. Cladel, T. Cooper, 2015, PloS one.

Mouse papillomavirus infection persists in mucosal tissues of an immunocompetent mouse strain and progresses to cancer

S. Brendle, N. Christensen, N. Cladel, 2017, Scientific Reports.

Impact of genetic changes to the CRPV genome and their application to the study of pathogenesis in vivo.

N. Christensen, N. Cladel, L. Budgeon, 2007, Virology.

Preclinical Model To Test Human Papillomavirus Virus (HPV) Capsid Vaccines In Vivo Using Infectious HPV/Cottontail Rabbit Papillomavirus Chimeric Papillomavirus Particles

N. Christensen, C. Buck, N. Cladel, 2006, Journal of Virology.

Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes.

R. Roden, H. Zayed, S. Brendle, 2015, Vaccine.

Antibody-Mediated Immune Subset Depletion Modulates the Immune Response in a Rabbit (Oryctolagus cuniculus) Model of Epstein-Barr Virus Infection.

C. Sample, S. Brendle, N. Christensen, 2020, Comparative medicine.

Antibody detection in tear samples as a surrogate to monitor host immunity against papillomavirus infections in vaccinated and naturally infected hosts.

S. Brendle, S. Bywaters, N. Christensen, 2014, The Journal of general virology.

Papillomavirus can be transmitted through the blood and produce infections in 1 blood recipients : Evidence from two animal models 2 3

S. Brendle, Zhi-Ming Zheng, N. Cladel, 2019 .

Tracking vaginal, anal and oral infection in a mouse papillomavirus infection model.

N. Christensen, R. Myers, N. Cladel, 2015, The Journal of general virology.

Depo Medroxyprogesterone (DMPA) Promotes Papillomavirus Infections but Does Not Accelerate Disease Progression in the Anogenital Tract of a Mouse Model

V. Walter, S. Brendle, N. Christensen, 2022, Viruses.

The Mouse Papillomavirus Infection Model

N. Christensen, N. Cladel, L. Budgeon, 2017, Viruses.

Formulation of cidofovir improves the anti-papillomaviral activity of topical treatments in the CRPV/rabbit model.

N. Christensen, N. Cladel, Jiafen Hu, 2014, Antiviral research.

Treatment of latent rabbit and human papillomavirus infections with 9-(2-phosphonylmethoxy)ethylguanine (PMEG).

J. C. Martin, J. Kreider, K. Balogh, 1990, Antiviral research.

Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles

M. Boxus, S. Brendle, N. Christensen, 2016, Journal of Virology.

Papillomavirus DNA complementation in vivo.

N. Christensen, N. Cladel, L. Budgeon, 2009, Virus research.

A Comparative Study on Delivery of Externally Attached DNA by Papillomavirus VLPs and Pseudoviruses

S. Brendle, N. Christensen, S. Alam, 2021, Vaccines.

Mouse Papillomavirus L1 and L2 Are Dispensable for Viral Infection and Persistence at Both Cutaneous and Mucosal Tissues

S. Brendle, N. Christensen, N. Cladel, 2021, Viruses.

Establishment of a Cottontail Rabbit Papillomavirus/HLA-A2.1 Transgenic Rabbit Model

N. Christensen, N. Cladel, L. Budgeon, 2007, Journal of Virology.

Wounding prior to challenge substantially improves infectivity of cottontail rabbit papillomavirus and allows for standardization of infection.

N. Christensen, N. Cladel, Jiafen Hu, 2008, Journal of virological methods.

Differences in methodology, but not differences in viral strain, account for variable experimental outcomes in laboratories utilizing the cottontail rabbit papillomavirus model.

N. Christensen, N. Cladel, Jiafen Hu, 2010, Journal of virological methods.

Vaccine generated immunity targets an HPV16 E7 HLA-A2.1-restricted CD8(+) T cell epitope relocated to an early gene or a late gene of the cottontail rabbit papillomavirus (CRPV) genome in HLA-A2.1 transgenic rabbits.

N. Christensen, N. Cladel, Callie E Bounds, 2011, Vaccine.

Detection of L1, infectious virions and anti-L1 antibody in domestic rabbits infected with cottontail rabbit papillomavirus.

N. Christensen, N. Cladel, L. Budgeon, 2007, The Journal of general virology.

Passive Immunization with a Single Monoclonal Neutralizing Antibody Protects against Cutaneous and Mucosal Mouse Papillomavirus Infections

V. Walter, S. Brendle, N. Christensen, 2022, Journal of virology.

Mouse papillomavirus infections spread to cutaneous sites with progression to malignancy.

D. Gotte, N. Christensen, Zhi-Ming Zheng, 2017, The Journal of general virology.

Secondary Infections, Expanded Tissue Tropism, and Evidence for Malignant Potential in Immunocompromised Mice Infected with Mus musculus Papillomavirus 1 DNA and Virus

N. Christensen, N. Cladel, T. Cooper, 2013, Journal of Virology.

Humans with inherited T cell CD28 deficiency are susceptible to skin papillomaviruses but are otherwise healthy

Mark M. Davis, J. Casanova, L. Notarangelo, 2021, Cell.

Papillomavirus Particles Assembled in 293TT Cells Are Infectious In Vivo

N. Christensen, N. Cladel, L. Budgeon, 2006, Journal of Virology.

Synonymous codon changes in the oncogenes of the cottontail rabbit papillomavirus lead to increased oncogenicity and immunogenicity of the virus.

N. Christensen, N. Cladel, L. Budgeon, 2013, Virology.

CRPV Genomes with Synonymous Codon Optimizations in the CRPV E7 Gene Show Phenotypic Differences in Growth and Altered Immunity upon E7 Vaccination

N. Christensen, N. Cladel, Jiafen Hu, 2008, PloS one.

Strong and Specific Protective and Therapeutic Immunity Induced by Single HLA-A2.1 Restricted Epitope DNA Vaccine in Rabbits

N. Christensen, N. Cladel, T. Schell, 2009 .

Using HLA-A2.1 Transgenic Rabbit Model to Screen and Characterize New HLA-A2.1 Restricted Epitope DNA Vaccines.

N. Christensen, N. Cladel, T. Schell, 2010, Journal of vaccines & vaccination.

Long-peptide therapeutic vaccination against CRPV-induced papillomas in HLA-A2.1 transgenic rabbits.

N. Christensen, N. Cladel, L. Budgeon, 2014, Trials in vaccinology.

BET bromodomain inhibitors show anti‐papillomavirus activity in vitro and block CRPV wart growth in vivo

R. Prinjha, Kevin Lee, S. Brendle, 2018, Antiviral research.

The environmental pollutant and tobacco smoke constituent Dibenzo[def,p]chrysene is a Co-factor for malignant progression of mouse oral papillomavirus infections.

V. Walter, S. Amin, S. Brendle, 2020, Chemico-biological interactions.

Papillomavirus can be transmitted through the blood and produce infections in blood recipients: Evidence from two animal models

S. Brendle, Zhi-Ming Zheng, N. Cladel, 2019, bioRxiv.

Immune Responses in Oral Papillomavirus Clearance in the MmuPV1 Mouse Model

K. El-Bayoumy, Sarah A. Brendle, Jiafen Hu, 2023, Pathogens.

FLT3L governs the development of partially overlapping hematopoietic lineages in humans and mice

S. Tangye, C. Deswarte, K. Claeys, 2024, Cell.